Showing results (1951-1960 of 2,138) with videos related to

Sort By:
Pageof 214
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 17, 2017
Using CRISPR-Cas9 to Generate Gene-Corrected Autologous iPSCs for the Treatment of Inherited Retinal DegenerationErin R Burnight, Manav Gupta, Luke A Wiley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 14, 2022
SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic LeukemiaAnjali S Advani, Anna Moseley, Kristen M O'Dwyer, et al.
Blood|February 7, 2008
High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemiaMarc M Loriaux, Ross L Levine, Jeffrey W Tyner, et al.
The International Journal of Neuropsychopharmacology|December 12, 2025
Diazepam modulates anterior cingulate glutamate levels in people at clinical high-risk for psychosisAmanda Kiemes, Nicholas R Livingston, Paulina B Lukow, et al.
Journal for Immunotherapy of Cancer|September 23, 2024
MTA-cooperative PRMT5 inhibitors enhance T cell-mediated antitumor activity in MTAP-loss tumorsSi Chen, Jiakai Hou, Roshni Jaffery, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2004
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B studySherif S Farag, Amy S Ruppert, Krzysztof Mrózek, et al.
Nature|July 4, 1996
Characterization of a multicomponent receptor for GDNFJ J Treanor, L Goodman, F de Sauvage, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 20, 2009
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathologySagnik Bhattacharyya, Paul D Morrison, Paolo Fusar-Poli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A phase 1 dose-escalation study of Navitoclax, Venetoclax, and DecitabineEvan C Chen, Yiwen Liu, Hayden L Bell, et al.
Pageof 214